The Louisiana Office of State Procurement has published Request for Proposal (RFP) for Enrollment Broker for Louisiana Department of Health (LDH), Solicitation Doc728430015.
The original Notice to Proposers was issued June 11, 2026. Louisiana LaPAC currently lists the solicitation as open until September 29, 2026 at 10:00 AM CT. The procurement has multiple schedule amendments, including Addendum 4 issued August 24, 2026 and Addendum 5, Questions and Answers, issued September 14, 2026.
Procurement access: The official Notice to Proposers directs suppliers to Louisiana eProcurement Solutions by Ariba (LESA), SAP Ariba event 1110015806. Suppliers must sign in with an SAP Ariba Business Network account, or register for one, to view and respond to the full RFP.
Funding/contract value: The publicly accessible controlling notices do not state a maximum contract value or total procurement budget. Atlas does not infer a value from third-party estimates.
Requirements and addenda: LaPAC lists Addendum 1, Revised Posting Link, issued June 17; Addendum 2, Schedule of Event Change, issued July 16; Addendum 3, Schedule of Event Change, issued August 4; Addendum 4, Schedule of Events Change, issued August 24; and Addendum 5, Questions and Answers, issued September 14. The current LaPAC listing shows the proposal deadline as September 29, 2026 at 10:00 AM CT. Because the detailed RFP package is behind authenticated LESA/Ariba access, detailed scope, bidder qualifications, mandatory forms, references, pricing, cost-share or match requirements, subcontracting rules, and complete submission requirements remain subject to controlling-document verification.
Contact: Samuel Miller, Louisiana Office of State Procurement, samuel.miller@la.gov.
Atlas analysis: Atlas Opportunity Score 61/100. N9+ Fit Score 0/100. The Nonagon N9+ remote physical examination platform is not an enrollment-broker or benefits-enrollment administration solution. No verified Dr. Miltie/QC Healthcare capability establishes the required enrollment-broker administration function. Atlas therefore classifies this as No Bid / Do Not Pursue on currently verified capabilities.
Next action: Continue monitoring LaPAC for any further schedule changes or addenda. Re-score only if controlling materials reveal a discrete clinical-technology or subcontracting scope that legitimately fits a verified Dr. Miltie capability.